Cases & Deals

Share

CARMAT completes €50 million capital increase

April 2016

Client(s) CARMAT SA

Jones Day represented CARMAT SA, a designer and developer of the world's most advanced heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, in connection with its €50 million (US$56.2 million) reserved capital increase between CARMAT, its core shareholders, and a pool of strategic investors including Airbus Group (Matra Défense), Truffle Capital, CorNovum (Bpifrance), ALIAD (Air Liquide), and the family offices of Mr. Pierre Bastid and Mr. Antonino Ligresti.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.